CRH Medical logo CRH Medical Corp (NYSEAMERICAN:CRHM) – Equities research analysts at Clarus Securities cut their FY2019 earnings per share estimates for CRH Medical in a report released on Wednesday, March 20th. Clarus Securities analyst N. Atkinson now expects that the company will post earnings of $0.01 per share for the year, down from their prior estimate of $0.07.
Other equities research analysts also recently issued reports about the company. Zacks Investment Research raised CRH Medical from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a report on Tuesday. TD Securities reaffirmed a “buy” rating on shares of CRH Medical in a report on Tuesday, January 8th.
NYSEAMERICAN CRHM opened at $2.62 on Thursday. CRH Medical has a 1-year low of $2.40 and a 1-year high of $4.50.
CRH Medical (NYSEAMERICAN:CRHM) last released its earnings results on Wednesday, March 13th. The company reported $0.02 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.02. The firm had revenue of $32.02 million for the quarter, compared to analyst estimates of $31.40 million.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. ClariVest Asset Management LLC acquired a new stake in CRH Medical during the third quarter valued at approximately $154,000. Acadian Asset Management LLC acquired a new position in shares of CRH Medical in the 3rd quarter worth approximately $354,000. Two Sigma Advisers LP boosted its holdings in shares of CRH Medical by 12.6% in the 4th quarter. Two Sigma Advisers LP now owns 220,300 shares of the company’s stock worth $675,000 after acquiring an additional 24,700 shares in the last quarter. Ativo Capital Management LLC boosted its holdings in shares of CRH Medical by 7.1% in the 3rd quarter. Ativo Capital Management LLC now owns 300,079 shares of the company’s stock worth $1,185,000 after acquiring an additional 20,002 shares in the last quarter. Finally, Mackenzie Financial Corp acquired a new position in shares of CRH Medical in the 4th quarter worth approximately $1,413,000.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O’Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Featured Article: What are the FAANG Stocks? Earnings History and Estimates for CRH Medical (NYSEAMERICAN:CRHM) Receive News & Ratings for CRH Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CRH Medical and related companies with MarketBeat.com’s FREE daily email newsletter .
Click here to view original web page at CRH Medical Corp (CRHM) Forecasted to Post FY2019 Earnings of $0.01 Per Share